Cardinal Health, Inc. is an integrated healthcare services and products company based in Dublin, Ohio, with operations in the United States and internationally. The company serves a wide range of healthcare providers, including hospitals, pharmacies, and clinical laboratories, through its two main segments: Pharmaceutical and Medical. The Pharmaceutical segment focuses on distributing branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter products, while also offering services such as medication therapy management and pharmacy management. The Medical segment manufactures and distributes a variety of medical, surgical, and laboratory products, including wound care and cardiovascular items, as well as providing supply chain solutions. Founded in 1979, Cardinal Health emphasizes customized solutions that enhance the performance of healthcare facilities and improve patient outcomes.
GI Alliance is a network of best-in-class gastroenterologists who have joined together to provide superior clinical outcomes for our patients.
Advanced Diabetes Supply
Acquisition in 2024
Advanced Diabetes Supply is a national distributor of Durable Medical Equipment specializing in diabetes supplies. ADS holds the most valued accreditations in the diabetes supply industry, including NABP, URAC, and NABP. Its focus on the industry with innovation, knowledge and unparalleled commitment to exceeding service standards highlights Advanced Diabetes Supply's dedication to customer outcomes.
Integrated Oncology Network
Acquisition in 2024
Integrated Oncology Network is a prominent provider of oncology practice management and advisory services in the United States. The company specializes in offering comprehensive management solutions for cancer centers, hospitals, oncology groups, and physician practices. Its services encompass oncology center development, transaction services, project development, financing, and management, with a particular focus on radiation oncology operations. Integrated Oncology Network also provides essential administrative support, including billing and collection, accounting, compliance, and dosimetry services. By partnering with healthcare providers, the company aims to enhance operational efficiency and improve patient care within the oncology sector.
Innara Health
Acquisition in 2024
Innara Health, Inc. specializes in developing neonatal care technologies aimed at improving the health and development outcomes for preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device that supports the development of non-nutritive sucking skills in newborns, which is crucial for feeding. This system assists caregivers in neonatal and pediatric intensive care units by providing insights into effective treatment strategies for infants facing feeding challenges. Founded in 2006 and based in Olathe, Kansas, Innara Health was previously known as KCBioMedix, Inc. until it rebranded in 2013. The company’s innovations are focused on enhancing the quality of life for infants and their families, as well as improving overall feeding outcomes in hospital settings.
Specialty Networks
Acquisition in 2024
Specialty Networks is a technology-driven organization that supports independent specialty healthcare providers across the United States. It offers a range of services designed to enhance practice operations, including population health management, patient engagement, clinical research, and workflow automation. By focusing on the needs of private practices, Specialty Networks aims to deliver innovative solutions that help these providers achieve excellence in their operations and improve their ability to deliver value-based care. The organization's comprehensive approach adds significant value to both specialty providers and their industry clients.
RxLive
Series A in 2022
RxLive, Inc. is a telehealth company based in Saint Petersburg, Florida, that specializes in providing comprehensive medication management services through its online video chat platform. Founded in 2017, RxLive connects patients with clinical pharmacists, enabling them to receive personalized counseling and concierge pharmacy services. The platform aims to enhance patient access to medications and improve overall health outcomes by facilitating direct communication between patients and pharmacists.
Scala Med
Acquisition in 2022
ScalaMed has created the most transformative piece of real-estate in healthcare that embeds into any health App (B2B/SaaS), utilizing prescription fulfillment as the gateway of patient access & engagement.
Medically Home Group, Inc. is a Boston-based company that specializes in delivering virtual hospital services, enabling patients to receive medical care in the comfort of their homes. Founded in 2016, the company offers a comprehensive program that addresses various medical conditions, including heart failure, pneumonia, chronic obstructive pulmonary disease (COPD), and urinary tract infections, among others. By utilizing a technology-enabled platform, Medically Home connects patients with caregivers and facilitates monitoring and communication for individuals with high-acuity illnesses. This approach allows patients and their families to access centralized, on-demand acute medical care management, effectively shifting the focus of healthcare from traditional hospital settings to home-based care.
Ember LifeSciences
Corporate Round in 2021
Ember LifeSciences is transforming the logistics of temperature-sensitive pharmaceuticals with its innovative cold chain technology. The company's flagship product, the Ember Cube, is a self-refrigerated, cloud-based shipping box designed to ensure that life-saving medicines are transported within the required temperature range. This technology not only guarantees the integrity of the medicines upon arrival but also enables live tracking of shipments, enhancing transparency for businesses. By optimizing the shipping process, Ember aims to improve patient outcomes, save lives, and significantly reduce the millions of pounds of waste generated from traditional packing materials in the pharmaceutical industry.
Vineti
Series C in 2020
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.
Vineti
Series C in 2020
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.
Medically Home
Series B in 2019
Medically Home Group, Inc. is a Boston-based company that specializes in delivering virtual hospital services, enabling patients to receive medical care in the comfort of their homes. Founded in 2016, the company offers a comprehensive program that addresses various medical conditions, including heart failure, pneumonia, chronic obstructive pulmonary disease (COPD), and urinary tract infections, among others. By utilizing a technology-enabled platform, Medically Home connects patients with caregivers and facilitates monitoring and communication for individuals with high-acuity illnesses. This approach allows patients and their families to access centralized, on-demand acute medical care management, effectively shifting the focus of healthcare from traditional hospital settings to home-based care.
Mscripts
Acquisition in 2019
mscripts is the first comprehensive mobile solution designed specifically for pharmacies. mscripts enables a pharmacy's customer to manage prescriptions and related health information directly from their mobile device. Using their cell phone, a customer can be notified of prescriptions ready for pickup, refill prescriptions, receive dosage reminders, find pharmacies close to their current location, view health information, and manage their relationship with your pharmacy. Customers benefit from increased convenience and control, and mscripts’ tools help improve adherence. The pharmacy benefits from increased customer loyalty, improved customer service, and increased pharmacy revenue.
Mirixa
Acquisition in 2019
Mirixacorp is a provider of medication therapy management programs.
NaviHealth
Venture Round in 2018
naviHealth, Inc. specializes in managing post-acute healthcare services in the United States. The company develops software for post-acute care management and collaborates with health plans, hospitals, and providers to streamline care transitions. By employing evidence-based protocols and technology, naviHealth optimizes clinical and financial outcomes throughout the care continuum. Its services include clinical support, analytics, and decision support tools that help create customized patient-centric care plans and enhance provider networks. This approach not only improves patient outcomes and satisfaction but also reduces inpatient days and hospital readmissions. Founded in 2011 and headquartered in Brentwood, Tennessee, naviHealth also has offices in Newton, Massachusetts, and Conshohocken, Pennsylvania, and operates as a subsidiary of OptumHealth, Inc.
Medtronic - Patient Monitoring & Recovery
Acquisition in 2017
Medtronic - Patient Monitoring & Recovery Division is a deep vein thrombosis and nutritional insufficiency businesses.
TelePharm
Acquisition in 2016
TelePharm is a digital healthcare company that provides a cloud-based telepharmacy platform designed to enhance the connection between pharmacies and patients. The platform enables hospital pharmacies to reach patients at home or other locations, facilitating convenient access to quality pharmaceutical care. Key features include pill counting, digital prescription verification, and counseling conducted through HIPAA-compliant, secure video calls. By streamlining workflows, TelePharm's solutions aim to improve productivity while delivering patient-focused pharmacy services.
RainTree Oncology Services
Acquisition in 2016
RainTree Oncology Services provides leading-edge oral drug acquisition and management services that make a difference in the lives of cancer patients by: helping community oncology practices expand services and improve patient care, enhancing the economic model of community oncology practices and pioneering an integrated information network between physicians, payors and manufacturers to advance the state of the art in oral oncology. RainTree Oncology is physician centric, patient focused and community minded.
Enlace Health
Series B in 2016
Enlace Health provides a comprehensive payment management platform that addresses the challenges within the healthcare reimbursement process. By connecting payers, providers, and patients, the company facilitates various healthcare delivery models, including both retrospective and prospective programs. Its platform analyzes existing healthcare data to create bundled payments and generate related reports, allowing healthcare providers to effectively manage delivery costs while promoting value-based care. Through these solutions, Enlace Health aims to improve the sustainability and efficiency of the healthcare system.
NaviHealth
Acquisition in 2015
naviHealth, Inc. specializes in managing post-acute healthcare services in the United States. The company develops software for post-acute care management and collaborates with health plans, hospitals, and providers to streamline care transitions. By employing evidence-based protocols and technology, naviHealth optimizes clinical and financial outcomes throughout the care continuum. Its services include clinical support, analytics, and decision support tools that help create customized patient-centric care plans and enhance provider networks. This approach not only improves patient outcomes and satisfaction but also reduces inpatient days and hospital readmissions. Founded in 2011 and headquartered in Brentwood, Tennessee, naviHealth also has offices in Newton, Massachusetts, and Conshohocken, Pennsylvania, and operates as a subsidiary of OptumHealth, Inc.
Outcomes Incorporated
Acquisition in 2015
OutcomesMTM is the national leader in the design, delivery and administration of Medication Therapy Management programs. The company's service line benefits health care purchasers by delivering a cost-effective approach to advancing patient care and controlling utilization through the provision of patient-friendly, face-to-face Personal Pharmacist™ services.
Cordis
Acquisition in 2015
Developer and manufacturer of interventional vascular medical devices headquartered in Miami Lakes, Florida. The company specializes in the development and production of minimally-invasive cardiovascular technology products including drug-eluting stents, catheters, guidewires, and vena cava filters for the treatment of coronary and peripheral vascular diseases, enabling pharmacies, hospitals, health systems, ambulatory surgery centers, clinical laboratories and physician offices to focus on patient care while reducing costs and enhancing efficiency.
Emerge Medical
Acquisition in 2014
Emerge Medical reduces costs in the healthcare system by developing, manufacturing, and distributing orthopedic devices. Emerge Medica delivers cost savings of 40-60% to hospitals around the country by eliminating much of the unecessary cost traditionally associated with the medical device industry.
Access Closure
Acquisition in 2014
Access Closure, Inc. is a medical device company based in Mountain View, California, specializing in vascular closure solutions for interventional and diagnostic procedures. Founded in 2002, the company offers innovative products, including the Mynx delivery system. This device effectively seals arteriotomy sites using a water-soluble and extravascular sealant, which expands within the tissue by absorbing blood and subcutaneous fluids. Access Closure aims to simplify and enhance the process of vascular closure, addressing the complexities associated with these medical procedures.
KEW
Venture Round in 2014
KEW Group is a personalized oncology management company based in Cambridge, Massachusetts, founded in 2009. It specializes in DNA-based genomic testing and interpretation services, aiming to enhance cancer care through individualized treatment options. By leveraging proprietary oncology therapeutic pathways and personalized medicine tools, KEW Group utilizes genetic and genomic information to inform clinical decision-making in community oncology settings. The company's focus is on identifying genetic variants in solid tumors and matching them with targeted therapies, thereby improving treatment decisions and the overall quality of patient care. KEW Group is committed to advancing oncology precision medicine and expanding the capabilities of molecular labs in the field.
Wavemark
Acquisition in 2013
WaveMark, Inc. provides information products that enable hospitals and manufacturers to control and manage the flow of consumable medical devices. Its product enables to capture, store, and provide data via Web browser for manufacturers and hospitals. The company uses radio frequency identification technology to collect and report real time information in a hands free environment. WaveMark, Inc. was founded in 2003 and is based in Littleton, Massachusetts
HealthSpot
Venture Round in 2013
HealthSpot mission is to increase access to high quality, convenient and affordable healthcare services. We do this with the innovative application of technology to healthcare. Our telemedicine Care4 Station is the ultimate access point to better healthcare, using our powerful custom software platform to bring together patients and providers in convenient neighborhood locations. We have the tools to empower healthcare professionals, making healthcare smarter, simpler and more accessible for everyone. HealthSpot files for bankruptcy on Jan, 2016.
AssuraMed
Acquisition in 2013
AssuraMed is a mail-order, direct-to-customer provider of disposable medical products to chronic disease patients. The company operates through two segments, Independence Medical and Edgepark Medical Supplies. Independence Medical serves as an outsourced supply chain for over 12,000 commercial customers, including durable medical equipment suppliers, independent pharmacies and wholesale distributors. Edgepark contracts directly with over 600 managed care organizations (MCOs) to provide direct-to-patient home delivery of products to hundreds of thousands of patients, while also providing MCOs with value-added services that drive utilization, billing efficiencies and patient compliance.
MCD
Acquisition in 2012
MCD is a company that was acquired by Cardinal Health in 2012.
Dik Drug
Acquisition in 2012
Dik Drug is a company that was acquired by Cardinal Health in 2012.
Futuremed Health Care Products
Acquisition in 2011
Distributor of consumable nursing supplies.
Zuellig Pharma
Acquisition in 2010
Zuellig Pharma has been successfully serving the Asia healthcare market since 1922; during this time our network has expanded to cover the needs of 13 countries and regions. We consistently strive to deliver relevant tailored solutions, coupled with critical market insights, to enable our healthcare partners to best connect with and realize the full market potential of the fast-growing dynamic Asian markets.
Kinray
Acquisition in 2010
Kinray is a distributor of pharmaceutical, generic, health and beauty, and home health care products in the world. The company has a long-standing and proud tradition of providing reliable, trustworthy and impeccable service to its valued independent pharmacy customers. Kinray is a full line, full-service, wholesale distributor with the primary goal to provide each and every customer with fast, friendly and courteous service.
HLS Freight Services
Acquisition in 2010
HLS Freight Services is a company that was acquired by Cardinal Health in 2010.
Healthcare Solutions Holding
Acquisition in 2010
Provides health care management solutions that help patients' health care outcomes and in the delivery of health care services.
Borschow Hospital & Medical Supplies
Acquisition in 2008
Borschow Hospital & Medical Supplies, Inc. is the largest and most technologically-advanced distributor of pharmaceutical products.
Enturia
Acquisition in 2008
ChloraPrep® brand products are used widely in U.S. hospitals and surgery centers to disinfect the skin before surgical and vascular procedures to help prevent blood stream and surgical site infections, two of the most common types of health care-associated infections (HAIs) among patients.
Viasys Healthcare
Acquisition in 2007
Viasys Healthcare is a heath care company that focusses on respiratory, neuro-care and medical/surgical technologies. It engages in the manufacturing and distributing of medical products and instruments. The company was founded by Douglas DeVries, Randy Thurman in 1995 and is headquartered in Geispolsheim-Gare, France.
CareFusion
Acquisition in 2006
CareFusion is a provider of medical products and enterprise management solutions aimed at enhancing the safety and cost-effectiveness of healthcare. The company offers a range of medical technology products, including automated dispensing systems, patient identification solutions, respiratory ventilators, and surgical instruments that are essential for infection prevention, neurological monitoring, and diagnosis. By focusing on these areas, CareFusion assists healthcare organizations in achieving improvements in infection control, medication management, medical supply management, and respiratory care.
MedMined
Acquisition in 2006
MedMined, Inc. provides data mining analysis and related technical, clinical, and financial consulting services to the healthcare community.
ParMed Pharmaceuticals
Acquisition in 2006
ParMed Pharmaceuticals is a distributor of generic pharmaceuticals and medical supplies based in Niagara Falls, New York. With a history spanning 47 years, the company is recognized for providing high-quality pharmaceuticals, including tablets, capsules, and liquids. In addition to pharmaceuticals, ParMed offers a range of medical, laboratory, and surgical products, emphasizing competitive pricing and superior customer service.
Nitric Bio
Series A in 2006
NitricBio is a mid-stage specialty pharmaceutical company focused on the dermatology and podiatry markets, with two unique drug delivery technologies. The first technology involves the development and commercialization of topical nitric oxide gas. Nitric oxide has both direct and regulatory actions with known anti-infective and anti-inflammatory properties. The company's current focus is on the development of a treatment for moderate-to-severe tinea pedis (athlete's foot), which is currently in late Phase 2 clinical trials.
Denver Biomedical
Acquisition in 2006
Denver Biomedical, Inc. engages in the design, manufacture, and distribution of specialized medical products.
Geodax Technology
Acquisition in 2004
Geodax Technology firm owns and operates pharmacies.
Alaris Medical Systems
Acquisition in 2004
ALARIS Medical Systems ( www.alarismed.com ) develops and markets products for the safe delivery of intravenous (IV) medications. The Company's IV medication and infusion therapy delivery systems, software applications, needle-free disposables and related monitoring equipment are marketed in the United States and internationally. ALARIS' "smart" pumps, with the proprietary Guardrails(R) Safety Software, help to reduce the risks and costs of medication errors, help to safeguard patients and clinicians and gather and record clinical information for review, analysis and interpretation. The Company provides its products, professional and technical support and training services to over 5,000 hospital and health care systems, as well as alternative care sites, in more than 120 countries through its direct sales force and distributors.
Gala Biotech
Acquisition in 2003
Gala Biotech, established in 1996 and located in Middleton, Wisconsin, specializes in biopharmaceutical manufacturing and molecular biology. The company, which has grown to over 40 employees, including 16 PhDs, is known for its proprietary GPEx® technology, which facilitates the rapid creation of stable, high-expressing mammalian cell lines for various gene products. Originally focused on producing pharmaceutical proteins in the milk of transgenic cows, Gala has adapted its gene insertion technology to support the increasing demand for the discovery and stable expression of therapeutic proteins. This technology plays a crucial role in helping biotech researchers overcome the challenges associated with clinical development. To enhance its capabilities, Gala has established a 43,000 square-foot facility dedicated to GPEx®-based cell line development and cGMP-compliant protein production, reinforcing its commitment to meeting the needs of its biopharmaceutical partners.
Syncor
Acquisition in 2002
Syncor International Corporation is a provider of high technology health care services concentrating on nuclear pharmacy services, medical imaging, niche manufacturing and radiotherapy. In the nuclear pharmacy services business, Syncor compounds and dispenses radiopharmaceuticals for diagnostic and therapeutic use by nuclear medicine departments in hospitals and outpatient clinics. Syncor distributes these time-critical pharmaceuticals to more than 7,000 U.S.-based customers through an integrated network of 130 domestic and 19 international nuclear pharmacies. Medical imaging services are provided through an integrated network of 72 domestic and 19 internationally owned or operated facilities. Medical imaging operations are conducted by Syncor's wholly owned subsidiary, Comprehensive Medical Imaging, Inc. Syncor also owns or operates eight domestic and two international production facilities for positron emission tomography (PET) radiopharmaceuticals, and is a party to a series of agreements to make PET technology more accessible to healthcare providers and patients nationwide.
Boron, LePore & Associates
Acquisition in 2002
Boron LePore & Associates, Inc., provides integrated medical education to the health care industry. The company's services include strategic consultation, content development, accredited and non-accredited program development and execution, logistics management and a variety of internet-based solutions related to these services.
Magellan Laboratories
Acquisition in 2002
Magellan develops and tests early-stage drugs for more than 200 pharmaceutical and biotechnology companies,
Bindley Western Industries
Acquisition in 2000
Bindley Western Industries is a pharmaceutical distribution and services company.
Bergen Brunswig Corp
Acquisition in 2000
Bergen Brunswig Corporation ( www.bergenbrunswig.com ) is a supplier of pharmaceuticals, medical- surgical supplies and specialty health-care products as well as information management solutions and consulting services.
Esurg.com
Series B in 2000
Esurg.com, the most comprehensive and trusted online source for medical, surgical and pharmaceutical supplies and information. They designed Their Web site for the growing number of physician practices and clinics working outside traditional hospital settings — to give them an edge in the increasingly complex business of medicine.
WiseBear.com
Series A in 2000
WiseBear.com is an e-commerce platform and online community focused on helping people lead a more balanced life. The company was founded in 1999 and is based in New York, United States.
Automatic Liquid Packaging
Acquisition in 1999
Automatic Liquid Packaging is a manufacturer of sterile liquid pharmaceuticals and other health-care products in topical, oral, inhaled and ophthalmic formulations.
Allegiance Healthcare
Acquisition in 1999
Allegiance Healthcare is a Health Care company.
R.P. Scherer Corporation
Acquisition in 1998
An international oral drug delivery systems company.
Owen Healthcare
Acquisition in 1996
A provider of outsourced management services for hospital pharmacies and materials management departments.
PCI Pharma Services
Acquisition in 1996
PCI are an integrated full service provider and a trusted partner to leading companies in the global healthcare industry. It offers unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for their customers.
Pyxis Corporation
Acquisition in 1996
Pyxis offers a range of behavioral health services for its customers. Its services include pro-social skills acquisition, psychosocial rehabilitation, life skills training, tutoring, mentoring, parent support and coaching, family mentoring, attendant care, respite care, intensive in-home, crisis intervention, and support services. It facilitates behavioral aide, after school group support, and day camps. Pyxis was acquired by Cardinal Health in February 1996. Pyxis Corporation was founded in 1994.
Medicine Shoppe International
Acquisition in 1995
The Medicine Shoppe pharmacy was established in 1968 by St. Louis pharmacist, Michael Busch. Busch’s mission was to bring to his community a pharmacy that was both dedicated to personalized service and managed by the pharmacist. Busch’s pharmacist-run business model allowed him the freedom he needed to grow his business and simultaneously focus on the needs of his customers. It quickly proved successful.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.